Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
How Often Should Part D's Model Formulary Be Revised? USP And CMS Disagree
Apr 04 2011
•
By
Scott Steinke
More from Archive
More from Pink Sheet